- Yale Medicine UrologyGreenwich Hospital55 Holly Hill Lane, Ste 110Greenwich, CT 06830
Brian Shinder, MD
Biography
Brian Shinder, MD, is a urologic oncologist who treats kidney, prostate, and bladder cancer.
Dr. Shinder says he was drawn to urology because of its variety, both in terms of conditions he treats and the types of procedures he performs. “It’s rewarding in that we can treat people and, in some cases, cure them of their disease, but also restore their function so that they can live better lives,” he says.
For most urologic diseases, surgery can be done either with a minimally invasive approach or through traditional, open surgery. “Both options have their place in treatment; it’s a matter of figuring out what is best for each patient based on their outcome and lifestyle goals,” Dr. Shinder says. “I make sure patients understand their options and help them decide the best way to move forward with their treatment.”
It's also an exciting time for the field, Dr. Shinder notes. “Urology has been at the forefront of robotic surgery. And the field continues to push boundaries regarding what can be done with robotic surgery,” he says. “There are also other, newer platforms and technologies to treat various diseases, including kidney stones and enlarged prostates. Urology has also been at the forefront of using genetics and different molecular markers to help diagnose conditions and decide the best treatment for patients.”
Titles
- Assistant Professor
Education & Training
- Fellow, Urologic OncologyMemorial Sloan Kettering Cancer Center
- Resident, UrologyRutgers Robert Wood Johnson Medical School
- Intern, General SurgeryRutgers Robert Wood Johnson Medical School
- MDRutgers Robert Wood Johnson Medical School
- BSUniversity of Maryland
Additional Information
- ASCO Conquer Cancer Young Investigator Award: (2023)
- American Urologic Association (2017 - Present): Member
- Society of Urologic Oncology (2017 - Present): Member
- Lee G, Shinder B, Sadimin E, Stephenson R, Singer E. Chapter 30 The emerging genetic landscape of renal cell carcinoma. 2024, 447-460. DOI: 10.1016/b978-0-12-822824-1.00035-3.
- Shinder B, Kronstedt S, Hakimi A. Predictive Biomarkers in Advanced Renal Cell Carcinoma. 2023, 251-268. DOI: 10.1007/978-3-031-40901-1_11.
- Lichtbroun B, Shinder B, Sara T, Srivastava A, Saraiya B, Mayer T, Cristelli R, Sadimin E, Weiss R, Singer E. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation. Journal Of Kidney Cancer And VHL 2023, 10: 1-8. PMID: 37441361, PMCID: PMC10334999, DOI: 10.15586/jkcvhl.v10i3.254.
- Shinder B, Kim S, Srivastava A, Patel H, Jang T, Mayer T, Saraiya B, Ghodoussipour S, Singer E. Factors associated with clinical trial participation for patients with renal cell carcinoma. Urologic Oncology Seminars And Original Investigations 2023, 41: 208.e1-208.e8. PMID: 36868881, PMCID: PMC10106382, DOI: 10.1016/j.urolonc.2023.01.022.
- Cahill E, Tabakin A, Shinder B, Bramwit M, Saraiya B, Xu X, Salazar C, Zhou Z, Singer E. Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature. Journal Of Kidney Cancer And VHL 2022, 9: 32-38. PMID: 36118793, PMCID: PMC9431006, DOI: 10.15586/jkcvhl.v9i2.229.
- Yoshitake S, Shinder B, Dazen K, Smith C, Mayer T, Sadimin E, Singer E. Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature. Journal Of Kidney Cancer And VHL 2022, 9: 22-26. PMID: 36118790, PMCID: PMC9430971, DOI: 10.15586/jkcvhl.v9i2.212.
- Patel HV, Kim S, Srivastava A, Shinder BM, Sterling J, Saraiya B, Mayer TM, Ghodoussipour S, Jang TL, Singer EA. Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 2022, 20: 296-296.e9. PMID: 35105510, PMCID: PMC9149103, DOI: 10.1016/j.clgc.2022.01.001.
- Srivastava A, Shinder B, Singer EA. EDITORIAL COMMENT. Urology 2021, 158: 115. PMID: 34895625, DOI: 10.1016/j.urology.2021.04.076.
- Patel H, Srivastava A, Shinder B, Kim I, Singer E, Ghodoussipour S, Jang T. Factors Associated with Accurate Staging of Stage I and II Testicular Nonseminomatous Germ Cell Tumors (nsgct). Journal Of The American College Of Surgeons 2021, 233: e230. DOI: 10.1016/j.jamcollsurg.2021.08.622.
- Shinder B, Kim S, Patel H, Mayer T, Saraiya B, Jang T, Kim I, Singer E. MP19-08 DISPARITIES IN CLINICAL TRIAL PARTICIPATION FOR PATIENTS WITH RENAL CELL CARCINOMA AND PROSTATE CANCER. Journal Of Urology 2021, 206: e330-e330. DOI: 10.1097/ju.0000000000002004.08.
- Urologic Issues in Palliative Care3. Patel HV, Shinder BM, Metwalli AR, Pinto PA, Singer EA. Urologic Issues in Palliative Care. Principles and Practice of Palliative care and Support Oncology, 5e. Wolters Kluwer Health 2020. ISBN 978-1975143688
- Srivastava A, Patel HV, Kim S, Shinder B, Sterling J, Tabakin AL, Polotti CF, Saraiya B, Mayer T, Kim IY, Ghodoussipour S, Patel HD, Jang TL, Singer EA. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Urologic Oncology Seminars And Original Investigations 2020, 39: 247-257. PMID: 33223368, PMCID: PMC7574787, DOI: 10.1016/j.urolonc.2020.10.012.
- Nicolaro M, Portal D, Shinder B, Patel H, Singer E. The human microbiome and genitourinary malignancies. Annals Of Translational Medicine 2020, 8: 1245. PMID: 33178777, PMCID: PMC7607065, DOI: 10.21037/atm-20-2976.
- Shinder BM, Patel HV, Sterling J, Tabakin AL, Kim IY, Jang TL, Singer EA. Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documents. Urologic Oncology Seminars And Original Investigations 2020, 38: 609-614. PMID: 32507546, PMCID: PMC7260595, DOI: 10.1016/j.urolonc.2020.05.017.
- Patel H, Shinder B, Srinivasan R, Singer E. Challenges and opportunities in the management of metastatic renal cell carcinoma: combination therapy and the role of cytoreductive surgery. Current Opinion In Oncology 2020, 32: 240-249. PMID: 32195679, PMCID: PMC9788417, DOI: 10.1097/cco.0000000000000621.
- Findlay B, Shinder B, Fatima A, Sadimin E, Drachtman R, Parikh R, Singer E. Primary Renal Ewing Sarcoma: A Case Report and Review of the Literature. Journal Of Renal Cancer 2019, 2: 15-19. PMID: 32090210, PMCID: PMC7034944, DOI: 10.36959/896/603.
- Tabakin AL, Shinder BM, Kim S, Rivera-Nunez Z, Polotti CF, Modi PK, Sterling JA, Farber NJ, Radadia KD, Parikh RR, Kim IY, Saraiya B, Mayer TM, Singer EA, Jang TL. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. Clinical Genitourinary Cancer 2019, 18: e194-e201. PMID: 31818649, DOI: 10.1016/j.clgc.2019.10.018.
- Munshi F, Shinder B, Sadimin E, Mayer T, Singer E. Metastatic Prostate Cancer to the Renal Pelvis and Proximal Ureter: A Case Report and Review of the Literature. Cancer Studies And Therapeutics 2019, 4 PMID: 32148662, PMCID: PMC7059776.
- Shinder B, Sack J, Sadimin E, Tunuguntla H. A Case Study Evaluating the Diagnosis and Treatment of a Rare Mesenchymal Tumor. Urology 2019, 131: e1-e2. PMID: 31247212, DOI: 10.1016/j.urology.2019.06.019.
- Tabakin A, Kim S, Polotti C, Shinder B, Rivera-Nunez Z, Sterling J, Farber N, Radadia K, Kim I, Singer E, Jang T. Survival rates after retroperitoneal lymph node dissection (RPLND) for testicular seminoma. Journal Of Clinical Oncology 2019, 37: 534-534. DOI: 10.1200/jco.2019.37.7_suppl.534.
- Patel H, Srivastava A, Shinder B, Sadimin E, Singer E. Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system. Annals Of Translational Medicine 2019, 7: s33. PMID: 31032312, PMCID: PMC6462582, DOI: 10.21037/atm.2019.02.19.
- Farber NJ, Rivera-Núñez Z, Kim S, Shinder B, Radadia K, Sterling J, Modi PK, Goyal S, Parikh R, Mayer TM, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database. Urologic Oncology Seminars And Original Investigations 2018, 37: 26-32. PMID: 30446458, PMCID: PMC6295174, DOI: 10.1016/j.urolonc.2018.10.004.
- Yuh B, Kwon Y, Shinder B, Singer E, Jang T, Kim S, Stein M, Mayer T, Ferrari A, Lee N, Parikh R, Ruel N, Kim W, Horie S, Byun S, Ahlering T, Kim I. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer. Prostate International 2018, 7: 102-107. PMID: 31485434, PMCID: PMC6713798, DOI: 10.1016/j.prnil.2018.10.002.
- Shinder B, Shupe A, Lee G, Stein M, Kim I, Singer E. Role of the androgen signaling axis in genitourinary malignancies. Translational Cancer Research 2018, 7: 1135-1142. PMID: 30701159, PMCID: PMC6349041, DOI: 10.21037/tcr.2018.03.41.
- Benzon B, Glavaris SA, Simons BW, Hughes RM, Ghabili K, Mullane P, Miller R, Nugent K, Shinder B, Tosoian J, Fuchs EJ, Tran PT, Hurley PJ, Vuica-Ross M, Schaeffer EM, Drake CG, Ross AE. Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer. Prostate Cancer Prostatic Dis 2018, 21: 126-136. PMID: 29556048, DOI: 10.1038/s41391-018-0035-z.
- Farber N, Faiena I, Dombrovskiy V, Tabakin A, Shinder B, Patel R, Elsamra S, Jang T, Singer E, Weiss R. Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer. Bladder Cancer 2018, 4: 113-120. PMID: 29430511, PMCID: PMC5798533, DOI: 10.3233/blc-170162.
- Radadia K, Farber N, Shinder B, Polotti C, Milas L, Tunuguntla H. Management of Postradical Prostatectomy Urinary Incontinence: A Review. Urology 2017, 113: 13-19. PMID: 29031841, DOI: 10.1016/j.urology.2017.09.025.
- Farber N, Davis R, Grimsby G, Shinder B, Cannon G, Jacobs M, Ost M, Schneck F, Stephany H, Gargollo P, Dwyer M. Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patients. Canadian Journal Of Urology 2017, 24: 9038-9042. PMID: 28971794.
- Faiena I, Kim S, Farber N, Kwon Y, Shinder B, Patel N, Salmasi A, Jang T, Singer E, Kim W, Kim I. Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers. Oncotarget 2017, 5: 109783-109790. PMID: 29312648, PMCID: PMC5752561, DOI: 10.18632/oncotarget.21297.
- Shinder BM, Farber NJ, Weiss RE, Jang TL, Kim IY, Singer EA, Elsamra SE. Performing all major surgical procedures robotically will prolong wait times for surgery. Robotic Surgery Research And Reviews 2017, 4: 87-91. PMID: 28890901, PMCID: PMC5586216, DOI: 10.2147/rsrr.s135713.
- Shinder B, Rhee K, Farrell D, Farber N, Stein M, Jang T, Singer E. Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach. Frontiers In Oncology 2017, 7: 107. PMID: 28620578, PMCID: PMC5449498, DOI: 10.3389/fonc.2017.00107.
- Kim DK, Parihar JS, Kwon YS, Kim S, Shinder B, Lee N, Farber N, Ahlering T, Skarecky D, Yuh B, Ruel N, Kim WJ, Rha KH, Kim IY. Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study. Asian Journal Of Andrology 2017, 20: 9-14. PMID: 28440262, PMCID: PMC5753561, DOI: 10.4103/1008-682x.196852.
- American College of Surgeons Evidence-Based Decisions in Surgery: Management of Malignant Upper Urinary Tract ObstructionFarber N, Salib A, Shinder B, Modi P, Elsamra S, Singer E. American College of Surgeons Evidence-Based Decisions in Surgery: Management of Malignant Upper Urinary Tract Obstruction. Committee on Surgical Palliative Care. 2017
- Shinder B, Farber N, Mayer T, Singer E. Treatment of Multifocal Renal Cell Carcinoma in a Solitary Kidney With Nivolumab. Clinical Genitourinary Cancer 2016, 15: e165-e167. PMID: 27396730, PMCID: PMC5083235, DOI: 10.1016/j.clgc.2016.04.013.
- Hurley PJ, Sundi D, Shinder B, Simons BW, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing C, Isaacs SD, Berman DM, Rider JR, Jordahl KM, Mucci LA, Huang J, An SS, Park BH, Isaacs WB, Marchionni L, Ross AE, Schaeffer EM. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res 2016, 22: 448-58. PMID: 26446945, DOI: 10.1158/1078-0432.CCR-15-0256.
- Hurley PJ, Hughes RM, Simons BW, Huang J, Miller RM, Shinder B, Haffner MC, Esopi D, Kimura Y, Jabbari J, Ross AE, Erho N, Vergara IA, Faraj SF, Davicioni E, Netto GJ, Yegnasubramanian S, An SS, Schaeffer EM. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression. Cancer Res 2015, 75: 4322-34. PMID: 26294211, DOI: 10.1158/0008-5472.CAN-15-0024.
- Yale Medicine UrologyGreenwich Hospital55 Holly Hill Lane, Ste 110Greenwich, CT 06830
Biography
Brian Shinder, MD, is a urologic oncologist who treats kidney, prostate, and bladder cancer.
Dr. Shinder says he was drawn to urology because of its variety, both in terms of conditions he treats and the types of procedures he performs. “It’s rewarding in that we can treat people and, in some cases, cure them of their disease, but also restore their function so that they can live better lives,” he says.
For most urologic diseases, surgery can be done either with a minimally invasive approach or through traditional, open surgery. “Both options have their place in treatment; it’s a matter of figuring out what is best for each patient based on their outcome and lifestyle goals,” Dr. Shinder says. “I make sure patients understand their options and help them decide the best way to move forward with their treatment.”
It's also an exciting time for the field, Dr. Shinder notes. “Urology has been at the forefront of robotic surgery. And the field continues to push boundaries regarding what can be done with robotic surgery,” he says. “There are also other, newer platforms and technologies to treat various diseases, including kidney stones and enlarged prostates. Urology has also been at the forefront of using genetics and different molecular markers to help diagnose conditions and decide the best treatment for patients.”
Titles
- Assistant Professor
Education & Training
- Fellow, Urologic OncologyMemorial Sloan Kettering Cancer Center
- Resident, UrologyRutgers Robert Wood Johnson Medical School
- Intern, General SurgeryRutgers Robert Wood Johnson Medical School
- MDRutgers Robert Wood Johnson Medical School
- BSUniversity of Maryland
Additional Information
- ASCO Conquer Cancer Young Investigator Award: (2023)
- American Urologic Association (2017 - Present): Member
- Society of Urologic Oncology (2017 - Present): Member
- Lee G, Shinder B, Sadimin E, Stephenson R, Singer E. Chapter 30 The emerging genetic landscape of renal cell carcinoma. 2024, 447-460. DOI: 10.1016/b978-0-12-822824-1.00035-3.
- Shinder B, Kronstedt S, Hakimi A. Predictive Biomarkers in Advanced Renal Cell Carcinoma. 2023, 251-268. DOI: 10.1007/978-3-031-40901-1_11.
- Lichtbroun B, Shinder B, Sara T, Srivastava A, Saraiya B, Mayer T, Cristelli R, Sadimin E, Weiss R, Singer E. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation. Journal Of Kidney Cancer And VHL 2023, 10: 1-8. PMID: 37441361, PMCID: PMC10334999, DOI: 10.15586/jkcvhl.v10i3.254.
- Shinder B, Kim S, Srivastava A, Patel H, Jang T, Mayer T, Saraiya B, Ghodoussipour S, Singer E. Factors associated with clinical trial participation for patients with renal cell carcinoma. Urologic Oncology Seminars And Original Investigations 2023, 41: 208.e1-208.e8. PMID: 36868881, PMCID: PMC10106382, DOI: 10.1016/j.urolonc.2023.01.022.
- Cahill E, Tabakin A, Shinder B, Bramwit M, Saraiya B, Xu X, Salazar C, Zhou Z, Singer E. Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature. Journal Of Kidney Cancer And VHL 2022, 9: 32-38. PMID: 36118793, PMCID: PMC9431006, DOI: 10.15586/jkcvhl.v9i2.229.
- Yoshitake S, Shinder B, Dazen K, Smith C, Mayer T, Sadimin E, Singer E. Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature. Journal Of Kidney Cancer And VHL 2022, 9: 22-26. PMID: 36118790, PMCID: PMC9430971, DOI: 10.15586/jkcvhl.v9i2.212.
- Patel HV, Kim S, Srivastava A, Shinder BM, Sterling J, Saraiya B, Mayer TM, Ghodoussipour S, Jang TL, Singer EA. Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 2022, 20: 296-296.e9. PMID: 35105510, PMCID: PMC9149103, DOI: 10.1016/j.clgc.2022.01.001.
- Srivastava A, Shinder B, Singer EA. EDITORIAL COMMENT. Urology 2021, 158: 115. PMID: 34895625, DOI: 10.1016/j.urology.2021.04.076.
- Patel H, Srivastava A, Shinder B, Kim I, Singer E, Ghodoussipour S, Jang T. Factors Associated with Accurate Staging of Stage I and II Testicular Nonseminomatous Germ Cell Tumors (nsgct). Journal Of The American College Of Surgeons 2021, 233: e230. DOI: 10.1016/j.jamcollsurg.2021.08.622.
- Shinder B, Kim S, Patel H, Mayer T, Saraiya B, Jang T, Kim I, Singer E. MP19-08 DISPARITIES IN CLINICAL TRIAL PARTICIPATION FOR PATIENTS WITH RENAL CELL CARCINOMA AND PROSTATE CANCER. Journal Of Urology 2021, 206: e330-e330. DOI: 10.1097/ju.0000000000002004.08.
- Urologic Issues in Palliative Care3. Patel HV, Shinder BM, Metwalli AR, Pinto PA, Singer EA. Urologic Issues in Palliative Care. Principles and Practice of Palliative care and Support Oncology, 5e. Wolters Kluwer Health 2020. ISBN 978-1975143688
- Srivastava A, Patel HV, Kim S, Shinder B, Sterling J, Tabakin AL, Polotti CF, Saraiya B, Mayer T, Kim IY, Ghodoussipour S, Patel HD, Jang TL, Singer EA. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Urologic Oncology Seminars And Original Investigations 2020, 39: 247-257. PMID: 33223368, PMCID: PMC7574787, DOI: 10.1016/j.urolonc.2020.10.012.
- Nicolaro M, Portal D, Shinder B, Patel H, Singer E. The human microbiome and genitourinary malignancies. Annals Of Translational Medicine 2020, 8: 1245. PMID: 33178777, PMCID: PMC7607065, DOI: 10.21037/atm-20-2976.
- Shinder BM, Patel HV, Sterling J, Tabakin AL, Kim IY, Jang TL, Singer EA. Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documents. Urologic Oncology Seminars And Original Investigations 2020, 38: 609-614. PMID: 32507546, PMCID: PMC7260595, DOI: 10.1016/j.urolonc.2020.05.017.
- Patel H, Shinder B, Srinivasan R, Singer E. Challenges and opportunities in the management of metastatic renal cell carcinoma: combination therapy and the role of cytoreductive surgery. Current Opinion In Oncology 2020, 32: 240-249. PMID: 32195679, PMCID: PMC9788417, DOI: 10.1097/cco.0000000000000621.
- Findlay B, Shinder B, Fatima A, Sadimin E, Drachtman R, Parikh R, Singer E. Primary Renal Ewing Sarcoma: A Case Report and Review of the Literature. Journal Of Renal Cancer 2019, 2: 15-19. PMID: 32090210, PMCID: PMC7034944, DOI: 10.36959/896/603.
- Tabakin AL, Shinder BM, Kim S, Rivera-Nunez Z, Polotti CF, Modi PK, Sterling JA, Farber NJ, Radadia KD, Parikh RR, Kim IY, Saraiya B, Mayer TM, Singer EA, Jang TL. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. Clinical Genitourinary Cancer 2019, 18: e194-e201. PMID: 31818649, DOI: 10.1016/j.clgc.2019.10.018.
- Munshi F, Shinder B, Sadimin E, Mayer T, Singer E. Metastatic Prostate Cancer to the Renal Pelvis and Proximal Ureter: A Case Report and Review of the Literature. Cancer Studies And Therapeutics 2019, 4 PMID: 32148662, PMCID: PMC7059776.
- Shinder B, Sack J, Sadimin E, Tunuguntla H. A Case Study Evaluating the Diagnosis and Treatment of a Rare Mesenchymal Tumor. Urology 2019, 131: e1-e2. PMID: 31247212, DOI: 10.1016/j.urology.2019.06.019.
- Tabakin A, Kim S, Polotti C, Shinder B, Rivera-Nunez Z, Sterling J, Farber N, Radadia K, Kim I, Singer E, Jang T. Survival rates after retroperitoneal lymph node dissection (RPLND) for testicular seminoma. Journal Of Clinical Oncology 2019, 37: 534-534. DOI: 10.1200/jco.2019.37.7_suppl.534.
- Patel H, Srivastava A, Shinder B, Sadimin E, Singer E. Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system. Annals Of Translational Medicine 2019, 7: s33. PMID: 31032312, PMCID: PMC6462582, DOI: 10.21037/atm.2019.02.19.
- Farber NJ, Rivera-Núñez Z, Kim S, Shinder B, Radadia K, Sterling J, Modi PK, Goyal S, Parikh R, Mayer TM, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database. Urologic Oncology Seminars And Original Investigations 2018, 37: 26-32. PMID: 30446458, PMCID: PMC6295174, DOI: 10.1016/j.urolonc.2018.10.004.
- Yuh B, Kwon Y, Shinder B, Singer E, Jang T, Kim S, Stein M, Mayer T, Ferrari A, Lee N, Parikh R, Ruel N, Kim W, Horie S, Byun S, Ahlering T, Kim I. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer. Prostate International 2018, 7: 102-107. PMID: 31485434, PMCID: PMC6713798, DOI: 10.1016/j.prnil.2018.10.002.
- Shinder B, Shupe A, Lee G, Stein M, Kim I, Singer E. Role of the androgen signaling axis in genitourinary malignancies. Translational Cancer Research 2018, 7: 1135-1142. PMID: 30701159, PMCID: PMC6349041, DOI: 10.21037/tcr.2018.03.41.
- Benzon B, Glavaris SA, Simons BW, Hughes RM, Ghabili K, Mullane P, Miller R, Nugent K, Shinder B, Tosoian J, Fuchs EJ, Tran PT, Hurley PJ, Vuica-Ross M, Schaeffer EM, Drake CG, Ross AE. Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer. Prostate Cancer Prostatic Dis 2018, 21: 126-136. PMID: 29556048, DOI: 10.1038/s41391-018-0035-z.
- Farber N, Faiena I, Dombrovskiy V, Tabakin A, Shinder B, Patel R, Elsamra S, Jang T, Singer E, Weiss R. Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer. Bladder Cancer 2018, 4: 113-120. PMID: 29430511, PMCID: PMC5798533, DOI: 10.3233/blc-170162.
- Radadia K, Farber N, Shinder B, Polotti C, Milas L, Tunuguntla H. Management of Postradical Prostatectomy Urinary Incontinence: A Review. Urology 2017, 113: 13-19. PMID: 29031841, DOI: 10.1016/j.urology.2017.09.025.
- Farber N, Davis R, Grimsby G, Shinder B, Cannon G, Jacobs M, Ost M, Schneck F, Stephany H, Gargollo P, Dwyer M. Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patients. Canadian Journal Of Urology 2017, 24: 9038-9042. PMID: 28971794.
- Faiena I, Kim S, Farber N, Kwon Y, Shinder B, Patel N, Salmasi A, Jang T, Singer E, Kim W, Kim I. Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers. Oncotarget 2017, 5: 109783-109790. PMID: 29312648, PMCID: PMC5752561, DOI: 10.18632/oncotarget.21297.
- Shinder BM, Farber NJ, Weiss RE, Jang TL, Kim IY, Singer EA, Elsamra SE. Performing all major surgical procedures robotically will prolong wait times for surgery. Robotic Surgery Research And Reviews 2017, 4: 87-91. PMID: 28890901, PMCID: PMC5586216, DOI: 10.2147/rsrr.s135713.
- Shinder B, Rhee K, Farrell D, Farber N, Stein M, Jang T, Singer E. Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach. Frontiers In Oncology 2017, 7: 107. PMID: 28620578, PMCID: PMC5449498, DOI: 10.3389/fonc.2017.00107.
- Kim DK, Parihar JS, Kwon YS, Kim S, Shinder B, Lee N, Farber N, Ahlering T, Skarecky D, Yuh B, Ruel N, Kim WJ, Rha KH, Kim IY. Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study. Asian Journal Of Andrology 2017, 20: 9-14. PMID: 28440262, PMCID: PMC5753561, DOI: 10.4103/1008-682x.196852.
- American College of Surgeons Evidence-Based Decisions in Surgery: Management of Malignant Upper Urinary Tract ObstructionFarber N, Salib A, Shinder B, Modi P, Elsamra S, Singer E. American College of Surgeons Evidence-Based Decisions in Surgery: Management of Malignant Upper Urinary Tract Obstruction. Committee on Surgical Palliative Care. 2017
- Shinder B, Farber N, Mayer T, Singer E. Treatment of Multifocal Renal Cell Carcinoma in a Solitary Kidney With Nivolumab. Clinical Genitourinary Cancer 2016, 15: e165-e167. PMID: 27396730, PMCID: PMC5083235, DOI: 10.1016/j.clgc.2016.04.013.
- Hurley PJ, Sundi D, Shinder B, Simons BW, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing C, Isaacs SD, Berman DM, Rider JR, Jordahl KM, Mucci LA, Huang J, An SS, Park BH, Isaacs WB, Marchionni L, Ross AE, Schaeffer EM. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res 2016, 22: 448-58. PMID: 26446945, DOI: 10.1158/1078-0432.CCR-15-0256.
- Hurley PJ, Hughes RM, Simons BW, Huang J, Miller RM, Shinder B, Haffner MC, Esopi D, Kimura Y, Jabbari J, Ross AE, Erho N, Vergara IA, Faraj SF, Davicioni E, Netto GJ, Yegnasubramanian S, An SS, Schaeffer EM. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression. Cancer Res 2015, 75: 4322-34. PMID: 26294211, DOI: 10.1158/0008-5472.CAN-15-0024.
- Yale Medicine UrologyGreenwich Hospital55 Holly Hill Lane, Ste 110Greenwich, CT 06830
- Yale Medicine UrologyGreenwich Hospital55 Holly Hill Lane, Ste 110Greenwich, CT 06830